Connect Biopharma Holdings Limited (CNTB) has regained compliance with Nasdaq’s minimum bid price requirement. The company’s American Depositary Shares (ADSs) maintained a minimum closing bid price of $1.00 or more for at least 10 consecutive business days, as confirmed by Nasdaq’s Listing Qualifications Department on July 16, 2025. This allows CNTB’s ADSs to continue trading on the Nasdaq. Currently, CNTB trades at $1.5699, 3.09% lower on the NasdaqGM.

Read more at Nasdaq: Connect Biopharma Regains Nasdaq Compliance On Minimum Bid Price